Pyrexia, commonly known as fever, remains a frequently encountered symptom in clinical practice. This article aims to provide a comprehensive guide to its management, focusing on the latest evidence-based approaches.
Pyrexia is a physiological response to a variety of conditions, most commonly infection. It is defined as a temporary elevation in the body's thermoregulatory set-point, typically characterized by a body temperature above 38°C (100.4°F). Understanding its underlying cause is crucial to formulating an effective management plan.
The diagnostic approach to pyrexia involves a thorough history and physical examination, with particular attention to potential sources of infection, travel history, and exposure to toxins or drugs. Laboratory investigations, including complete blood count, blood cultures, and specific serological tests, may be necessary depending on the clinical context. Imaging studies may also be warranted in certain cases.
Management of pyrexia primarily involves treating the underlying cause. Antipyretic medications such as acetaminophen and non-steroidal anti-inflammatory drugs (NSAIDs) can be used to alleviate discomfort. However, their use should be judicious as fever is a natural defense mechanism of the body. In cases of hyperpyrexia (temperature >41.5°C or 106.7°F), immediate intervention to reduce body temperature is essential to prevent potential complications such as seizures and organ damage.
The prognosis of pyrexia is generally good with appropriate treatment. However, in cases of persistent or recurrent fever, a detailed evaluation for potential underlying conditions, including malignancies and autoimmune diseases, is warranted. Long-term management involves regular follow-up and monitoring, along with patient education on the significance of fever and when to seek medical help.
Pyrexia is a common symptom that requires a systematic approach for effective management. By understanding its causes and implementing evidence-based treatment strategies, clinicians can ensure optimal patient outcomes.
1.
A US health panel advises starting mammograms at age 40 rather than 50.
2.
TULSA Is Effective in Long-Term Prostate Cancer Control.
3.
J. Craig Venter, Who Won the Race to Sequence the Human Genome, Dies at 79
4.
In Sickle Cell Disease, Lovo-Cel is "Life-Changing, Transformative.".
5.
How Social Determinants of Health Are Linked to Outcomes in Multiple Myeloma
1.
Molecular Matching for Individualized Blood-Disorder Therapy
2.
Everything You Need To Know About Melanoma Choroid: Causes, Symptoms, and Treatment
3.
Drug Safety Surveillance of Long-Term Medication Effects in Cancer Survivorship
4.
HPV-Related Cervical Cancer: Advances in Screening, Preventiofn & Treatment
5.
Early Diagnosis of Lung Cancer Through Emerging Biomarkers
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Current Scenario of Cancer- The Incidence of Cancer in Men
2.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
3.
L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients
4.
Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL
5.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation